Flynn James E 13D and 13G filings for Abeona Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 5:23 pm Sale |
2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
Flynn James E | 869,565 3.390% |
-869,565 (-50.00%) |
Filing |
| 2023-02-10 09:58 am Unchanged |
2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
Flynn James E | 1,739,130 5.060% |
0 (Unchanged) |
Filing |
| 2022-11-16 4:47 pm Purchase |
2022-11-07 | 13G | Abeona Therapeutics Inc. ABEO |
Flynn James E | 1,739,130 5.060% |
1,739,130 (New Position) |
Filing |